Delivery Order SPE2DB24D1104-SPE2DB24FXTS1
Award Date 2/5/24
Potential Completion Date 2/6/24
Potential Value $2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,068.84 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the provision of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used to treat diabetes. This award is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation. The contract is for the delivery of 4,564,571,290 units of Lantus Solostar 100 unit/mL 3mL, a prescription insulin medication. The contract has a ceiling value of $1,420.88 and an ultimate completion date of May 13, 2024. This delivery order is issued against a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,375.20 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to supply 4564541285 Lantus Solostar 100 Unit/mL 3mL prefilled pens. This order does not have a set-aside designation and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
- This is a $8,455.38 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The contract has an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,868.40 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar 100 unit/mL 3mL medication. The contract has an ultimate completion date of October 30, 2024 and was not set aside for any specific business category. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to the Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Lantus Solostar 100 unit/ml 3ml insulin medication. The $2,280.56 firm fixed price contract has a completion date of July 1, 2024. Amerisourcebergen is the prime contractor for this award, which is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,958.74 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $1,267.16 for the supply of Lantus Solostar 100 unit/ml 3ml insulin pens. The contract was awarded on July 2, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a completion date of July 3, 2024. This order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. The...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,134.47, is for the delivery of Lantus Solostar 100 unit/ml 3ml, a type of insulin medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is December 10, 2024. The contract does not have a set-aside designation, indicating open...
- This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,219.16, is for the delivery of Lantus Solostar 100 unit/mL 3mL, a prescription insulin product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure and an ultimate completion date of September 12, 2024. This contract is not a set-aside, and it is associated with a larger Indefinite Delivery...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB24FXTS1Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,992.84 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of Lantus Solostar 100 unit/ml 3ml, a prescription insulin medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's military treatment programs and facilities globally. The contract does not have a set-aside designation.
Generated 7/18/24, 9:57 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 2/5/24 |